Elliott Levy
Director/Board Member bei OMEGA THERAPEUTICS, INC.
Vermögen: 1 219 $ am 31.03.2024
Profil
Elliott Levy, MD joined 5AM as a Venture Partner in 2022.
Dr. Levy has spent almost 25 years in leadership roles in the pharmaceutical industry, the last 7 at Amgen where he was the head of Clinical Development and R&D Strategy and Operations.
Over the course of his career, Dr. Levy played a major role in the development of 22 approved medicines in seven therapeutic areas at two companies (Bristol Myers Squibb and Amgen), including many ‘firsts’: the first modern immunotherapy for cancer (Yervoy), the first effective bispecific therapy for cancer (Blincyto), the first oncolytic virus for cancer (Imlygic),the first new cornerstone transplant therapy in 25 years (Nulojix), and the first specific preventative therapy for migraine (Aimovig), as well as numerous agents with first in class mechanisms.
Since leaving Amgen in May 2021, Dr. Lev
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUCANA PLC
0,01% | 31.12.2023 | 4 688 ( 0,01% ) | 1 219 $ | 31.03.2024 |
OMEGA THERAPEUTICS, INC.
-.--% | 07.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Elliott Levy
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Director/Board Member | 01.03.2021 |
| NUCANA PLC | Director/Board Member | 01.11.2021 |
| EDITAS MEDICINE, INC. | Director/Board Member | 11.04.2023 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Private Equity Investor | 01.01.2022 |
| The Boston Consulting Group | Consultant / Advisor | - |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Elliott Levy
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.05.2021 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Chairman | 01.09.2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.07.2014 |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Elliott Levy
| Yale School of Medicine | Doctorate Degree |
| The Wayne State University School of Medicine | Undergraduate Degree |
| Yale College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NUCANA PLC | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
| The Boston Consulting Group | |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Health Technology |
